Torrent Pharma on Monday reported a 24% jump in its second-quarter net profit after a surge in revenue from India, Brazil and German operations offset a decline in the U.S.
Its net profit in July-September at Rs 386 crore was 23.7% higher than Rs 312 crore net earning in the same period a year back, the company said in a statement.
Revenues soared 16% to Rs 2,660 crore.
Its India revenue was up 18% at Rs 1,444 crore while earnings from German operation was up 21 per cent and that from Brazil soared by 36%. This offset a 15% decline in US revenues.
Giving a break-up, Torrent said in India, "Market outperformance was led by continued double-digit growth in chronic therapies, revival in gastro demand, traction in the consumer division, and new launches".
Curatio's portfolio grew by 17%, led by strong growth in top focus brands.
In Brazil, growth was aided by the performance of top brands, new launches and growth in the generic segment. The growth momentum in Germany continues with new tender wins coupled with better conversion of existing tenders.
The growth in U.S. revenues, it said, "was impacted by loss of low margin business and lack of new launches."
RECOMMENDED FOR YOU
Torrent Pharma Announces Open Offer To Acquire Rs 6,843-Crore Stake In JB Chemicals
Sep 04, 2025
Stock Picks Today: Torrent Power, Reliance Industries, Apollo Hospitals On Brokerages' Radar
Sep 01, 2025
Lincoln Pharma Q1 Results: Net Profit Rises 17%
Aug 07, 2025
Torrent Pharma Share Price Gets Investec 'Buy' Call — JB Chemicals Acquisition to Boost Growth
Jul 25, 2025
POPULAR